openPR Logo
Press release

Global Herceptin Biosimilar Market 2018 | Industry Analysis, Market Share, Trends, Business Strategy and Forecast to 2013-2025

09-25-2018 09:47 AM CET | Energy & Environment

Press release from: QYResearch

/ PR Agency: QYR
Global Herceptin Biosimilar Market 2018 | Industry Analysis, Market Share, Trends, Business Strategy and Forecast to 2013-2025

Global Herceptin Biosimilar Market 2018 | Industry Analysis, Market Share, Trends, Business Strategy and Forecast to 2013-2025

This report studies the Herceptin Biosimilar market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Herceptin Biosimilar in these regions, from 2013 to 2025, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

    South America (Brazil etc.)

    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

    Mylan

    Amgen

    Mabion

    AryoGen Biopharma

    Genor Biopharma

    The Instituto Vital Brazil

    Celltrion

    Gedeon Richter

By the product type, the market is primarily split into

    Capsule

    Tablet

    Others

By the end users/application, this report covers the following segments

    Healthcare&Pharmaceuticals

    Others

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1826548.html  

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com

Web: www.qyresearchglobal.com

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Room 2901 VILI International Building No.167 Linhe West Road

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Herceptin Biosimilar Market 2018 | Industry Analysis, Market Share, Trends, Business Strategy and Forecast to 2013-2025 here

News-ID: 1260104 • Views:

More Releases from QYResearch

Whole House Automation Smart Home Solution Market Growth Opportunities and Forecast 2025 - 2031
Whole House Automation Smart Home Solution Market Growth Opportunities and Forec …
Los Angeles, United State: A newly published report titled "Global Whole House Automation Smart Home Solution Market Insights, Forecast to 2025-2031" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The global Whole House Automation Smart Home Solution market was valued at US$ 4218 million in 2024 and is anticipated to reach US$ 6363 million
Articular Goniometer Market Growth Trends and Forecast 2025 - 2031
Articular Goniometer Market Growth Trends and Forecast 2025 - 2031
Los Angeles, United State: A newly published report titled "Global Articular Goniometer Market Insights, Forecast to 2025-2031" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The global Articular Goniometer market was valued at US$ 7.8 million in 2024 and is anticipated to reach US$ 10.6 million by 2031, witnessing a CAGR of 4.5% during
Travel Management Company (TMC) Market Growth Opportunities and Forecast 2025 - 2031
Travel Management Company (TMC) Market Growth Opportunities and Forecast 2025 - …
Los Angeles, United State: A newly published report titled "Global Travel Management Company (TMC) Market Insights, Forecast to 2025-2031" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The global Travel Management Company (TMC) market was valued at US$ 25840 million in 2024 and is anticipated to reach US$ 37150 million by 2031, witnessing a
Copper Paste for PCB Market Growth Drivers and Forecast 2025 - 2031
Copper Paste for PCB Market Growth Drivers and Forecast 2025 - 2031
Los Angeles, United State: A newly published report titled "Global Copper Paste for PCB Market Insights, Forecast to 2025-2031" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The global Copper Paste for PCB market was valued at US$ 132 million in 2024 and is anticipated to reach US$ 186 million by 2031, witnessing a

All 5 Releases


More Releases for Herceptin

Herceptin Biosimilars Market: An Overview
Herceptin (trastuzumab) is a widely used monoclonal antibody that has been pivotal in the treatment of HER2-positive breast cancer. The introduction of biosimilars for Herceptin has revolutionized the pharmaceutical landscape, offering a cost-effective alternative to the original biologic. Biosimilars are highly similar to their reference products in terms of safety, efficacy, and quality, but they are more affordable. As healthcare costs continue to rise globally, biosimilars like Herceptin are becoming
Herceptin Biosimilar Market Accelerates 23.2% CAGR Forecast (2022-2030)
The global Herceptin biosimilar market has demonstrated significant growth in recent years, and this trend is expected to continue over the forecast period. Valued at USD 1,795 million in 2021, the market is projected to reach USD 11,287 million by 2030, reflecting a compound annual growth rate (CAGR) of 23.2% from 2022 to 2030. This robust growth is driven by several factors, including the rising prevalence of gastric and breast
Herceptin Biosimilar Market Size, Share | Growth - 2030
Exclusive Report by Ameco Research: Herceptin Biosimilar Market Size Projected to Reach USD 11,280 Million by 2030, Growing at 23% CAGR Ameco Research is proud to announce the launch of its latest market research report, Herceptin Biosimilar Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Herceptin Biosimilar Market | Industry Trends and Forecast 2022-2030
Acumen Research and Consulting has announced the addition of the "Herceptin Biosimilar Market" report to their offering. The Herceptin Biosimilar Market Report 2030 is an in depth study analyzing the current state of the Herceptin Biosimilar Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Herceptin Biosimilar Market provides analysis of global market covering the industry trends, recent
Herceptin Biosimilar Market to Discern Steadfast Expansion During 2029
Global Herceptin Biosimilar Market: Overview Growing number of people living with gastric cancers and metastatic (spread) breast cancer is expected to drive demand opportunities for enterprises working in the global herceptin biosimilar market. Herceptin refers to a monoclonal antibody mainly utilized in the treatment of critical cancers like gastric cancers and metastatic (spread) breast cancer. An upcoming research report on the global herceptin biosimilar market provides a complete analysis of this market.
United States Herceptin Biosimilar Market 2017
In this report, the United States Herceptin Biosimilar Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Herceptin Biosimilar in